Synergy Chc Corp. (SNYR) intrinsic value & 10-year financials

Synergy Chc Corp. (SNYR) has a Graham intrinsic value of $9.30 per share. Over the last 10 fiscal years revenue grew 146.2% a year to $30.4M, with an average return on invested capital of 106.7%.

Graham intrinsic value
$9.30
Revenue (FY2025)
$30.4M
Revenue growth (10-yr CAGR)
146.2%
ROIC (10-yr avg)
106.7%
Free cash flow (FY2025)
—

SNYR 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $30.4M -$12.3M -$1.27 — -27.8% -952.1%
FY2024 $34.8M $2.1M $0.28 — 16.7% -107.7%
FY2023 $42.8M $6.3M $0.86 — 25.3% -81.7%
FY2022 — — — — — —
FY2019 $29.4M -$9.2M -$0.10 — -27.1% 1272.7%
FY2018 $33.8M -$6.2M -$0.07 $1.2M -14.5% -70.5%
FY2017 $35.6M $499.6K $0.01 -$984.1K 5.1% 20.9%
FY2016 $34.8M -$796.2K — $5.7M 8.4% 37.3%
FY2015 $13.5M -$7.5M — -$652.1K 3.6% 40.3%
FY2014 $9.2K -$960.1K — — -10461.8% 801.1%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Synergy CHC Corp. is a consistent compounder, expanding top-line revenue at 146.2% annually over the past decade.

Synergy CHC Corp. has historically struggled to out-earn its cost of capital, averaging just -16.7% ROIC.

Over the decade, Synergy CHC Corp. shows that the company has leveraged its balance sheet to sustain operations.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Synergy CHC Corp. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $9.30 per share.

SNYR stock: frequently asked questions

What is the intrinsic value of Synergy Chc Corp. (SNYR) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, SNYR's intrinsic value is about $9.30 per share.

How fast has Synergy Chc Corp. grown?

Revenue went from $9.2K in fiscal 2014 to $30.4M in fiscal 2025, a compound annual growth rate of 146.2%. Net income was -$12.3M in fiscal 2025.

What is SNYR's return on invested capital?

Average ROIC over the last 10 fiscal years was 106.7%, and average return on equity was 211.8%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this SNYR data come from?

From Synergy Chc Corp.'s annual 10-K filings on SEC EDGAR, most recently filed May 14, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar medicinal chemicals & botanical products stocks